Kiely Wealth Advisory Group, Inc. Gilead Sciences, Inc. Transaction History
Kiely Wealth Advisory Group, Inc.
- $176 Billion
- Q1 2024
A detailed history of Kiely Wealth Advisory Group, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Kiely Wealth Advisory Group, Inc. holds 27 shares of GILD stock, worth $1,856. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27
Previous 27
-0.0%
Holding current value
$1,856
Previous $2.16 Million
16.33%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding GILD
# of Institutions
1,885Shares Held
1BCall Options Held
8.71MPut Options Held
8.02M-
Black Rock Inc. New York, NY123MShares$8.42 Billion0.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$7.89 Billion0.17% of portfolio
-
Capital World Investors Los Angeles, CA84.5MShares$5.81 Billion1.06% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.2MShares$4.21 Billion1.05% of portfolio
-
State Street Corp Boston, MA57.7MShares$3.97 Billion0.19% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $86.2B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...